Health
Therapy
Cancer Prevention

Heron Therapeutics

$19.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (0.21%) As of 2:55 PM EDT today
+$0.04 (0.21%) Today

Why Robinhood?

You can buy or sell HRTX and other stocks, options, ETFs, and crypto commission-free!

About HRTX

Heron Therapeutics, Inc. Common Stock, also called Heron Therapeutics, is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. Read More The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bio erodible, injectable and implantable delivery systems. Heron Therapeutics was founded in February 1983 and is headquartered in Redwood City, CA.

Employees
198
Headquarters
San Diego, California
Founded
1983
Market Cap
1.51B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
697.11K
High Today
$19.33
Low Today
$18.88
Open Price
$19.08
Volume
422.35K
52 Week High
$41.55
52 Week Low
$16.20

Collections

Health
Therapy
Cancer Prevention
Pharmaceutical
Biotechnology
Medical
Technology

HRTX Earnings

-$1.09
-$0.88
-$0.66
-$0.45
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.